WIP1 Phosphatase as a Potential Therapeutic Target in Neuroblastoma
Mark C. Richter(GlaxoSmithKline (United States)), Rakesh Kumar(GlaxoSmithKline (United States))
Cited by 67
Related Papers
AKT inhibitor, GSK690693, induces growth inhibition and apoptosis in acute lymphoblastic leukemia cell lines
|Blood|2008|165
Insulin-like Growth Factor Receptor as a Therapeutic Target in Head and Neck Cancer
|Clinical Cancer Research|2007|141